BPC
PPH icon

Banque Pictet & Cie’s VanEck Pharmaceutical ETF PPH Stock Holding History

Banque Pictet & Cie’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,400
Closed -$453K – 418
2015
Q2 		$453K Sell
6,400
-200
-3% -$14.4K 0.04% 210
2015
Q1 		$464K Buy
6,600
+200
+3% +$13.6K 0.01% 327
2014
Q4 		$411K Hold
6,400
– – 0.01% 333
2014
Q3 		$407K Hold
6,400
– – 0.01% 319
2014
Q2 		$397K Hold
6,400
– – 0.01% 304
2014
Q1 		$374K Hold
6,400
– – 0.01% 300
2013
Q4 		$340K Buy
+6,400
New +$324K 0.01% 286

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return
AHS
Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Banque Pictet & Cie's PPH Position: Q3 2015 in Review

Banque Pictet & Cie sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2015, closing a stake of 6,400 shares — an estimated $453K sold.

Banque Pictet & Cie first reported a position in PPH in Q4 2013 and held it in 7 quarters. The position peaked at $464K in Q1 2015. 60 funds tracked by Wall St. Rank hold PPH as of Q3 2015.

  • Banque Pictet & Cie reported no remaining VanEck Pharmaceutical ETF position as of Q3 2015 after selling out during the quarter.
  • Banque Pictet & Cie sold 6,400 VanEck Pharmaceutical ETF shares in Q3 2015, an estimated $453K.
  • Banque Pictet & Cie first reported a position in VanEck Pharmaceutical ETF in Q4 2013 and held it in 7 quarters.
  • Banque Pictet & Cie's VanEck Pharmaceutical ETF position peaked at $464K in Q1 2015.
  • 60 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2015.

Based on Banque Pictet & Cie's 13F filing for Q3 2015, filed 10 Nov 2015.